# OnCo record phergain (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/phergain/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "phergain", "NCT03161353" ;
  schema:name "PHERGain"@en ;
  schema:description "Using an early PET scan to spot responders let a third of women be cured of HER2-positive breast cancer without any chemotherapy."@en ;
  schema:url <https://onco.cc/trials/phergain/> ;
  schema:dateModified "2026-09-07"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT03161353> ;
  onco:status "positive" ;
  onco:phase "2" ;
  schema:startDate "2017-06-26" ;
  onco:cancers <https://onco.cc/cancers/breast-her2-positive/>, <https://onco.cc/cancers/her2-positive-early-breast-cancer/> ;
  onco:technologies <https://onco.cc/technologies/fdg-pet/> ;
  onco:drugs <https://onco.cc/drugs/trastuzumab/>, <https://onco.cc/drugs/pertuzumab/> ;
  onco:terms <https://onco.cc/terms/pcr/> ;
  onco:people <https://onco.cc/people/aleix-prat/>, <https://onco.cc/people/javier-cortes/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-phergain-lancet-oncol-2021/>, <https://onco.cc/key-papers/paper-phergain-lancet-2024-update/> .